{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:12:52Z","timestamp":1761581572799,"version":"build-2065373602"},"reference-count":29,"publisher":"BMJ","issue":"9","funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2017,7,3]]},"published-print":{"date-parts":[[2017,9]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>A retained placenta is diagnosed when the placenta is not delivered following delivery of the baby. It is a major cause of postpartum haemorrhage and treated by the operative procedure of manual removal of placenta (MROP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The aim of this pragmatic, randomised, placebo-controlled, double-blind UK-wide trial, with an internal pilot and nested qualitative research to adjust strategies to refine delivery of the main trial, is to determine whether sublingual glyceryl trinitrate (GTN) is (or is not) clinically and cost-effective for (medical) management of retained placenta. The primary clinical outcome is need for MROP, defined as the placenta remaining undelivered 15\u2009min poststudy treatment and\/or being required within 15\u2009min of treatment due to safety concerns. The primary safety outcome is measured blood loss between administration of treatment and transfer to the postnatal ward or other clinical area. The primary patient-sided outcome is satisfaction with treatment and a side effect profile. The primary economic outcome is net incremental costs (or cost savings) to the National Health Service of using GTN versus standard practice. Secondary outcomes are being measured over a range of clinical and economic domains. The primary outcomes will be analysed using linear models appropriate to the distribution of each outcome. Health service costs will be compared with multiple trial outcomes in a cost-consequence analysis of GTN versus standard practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>Ethical approval has been obtained from the North-East Newcastle &amp; North Tyneside 2 Research Ethics Committee (13\/NE\/0339). Dissemination plans for the trial include the Health Technology Assessment Monograph, presentation at international scientific meetings and publication in high-impact, peer-reviewed journals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"NCT88609453\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\">NCT88609453<\/jats:ext-link>\n                      ; Pre-results.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-017134","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:09:15Z","timestamp":1761581355000},"page":"e017134","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["A pragmatic group sequential, placebo-controlled, randomised trial to determine the effectiveness of glyceryl trinitrate for retained placenta (GOT-IT): a study protocol"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct88609453","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct34755982","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct13204258","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0371-2014","authenticated-orcid":false,"given":"Fiona C","family":"Denison","sequence":"first","affiliation":[{"name":"Tommy\u2019s Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen\u2019s Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Norrie","sequence":"additional","affiliation":[{"name":"The Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Lawton","sequence":"additional","affiliation":[{"name":"Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane E","family":"Norman","sequence":"additional","affiliation":[{"name":"Tommy\u2019s Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen\u2019s Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Scotland","sequence":"additional","affiliation":[{"name":"Health Economics Research Unit, Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys C","family":"McPherson","sequence":"additional","affiliation":[{"name":"The Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"McDonald","sequence":"additional","affiliation":[{"name":"The Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Forrest","sequence":"additional","affiliation":[{"name":"The Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jemma","family":"Hudson","sequence":"additional","affiliation":[{"name":"The Centre for Healthcare Randomised Trials (CHaRT), Health Services Research Unit, University of Aberdeen, Aberdeen, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Brewin","sequence":"additional","affiliation":[{"name":"Tommy\u2019s, Nicholas House, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Peace","sequence":"additional","affiliation":[{"name":"Tommy\u2019s Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen\u2019s Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Clarkson","sequence":"additional","affiliation":[{"name":"Tommy\u2019s Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen\u2019s Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheonagh","family":"Brook-Smith","sequence":"additional","affiliation":[{"name":"Simpson\u2019s Centre for Reproductive Health, Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Morrow","sequence":"additional","affiliation":[{"name":"Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Hallowell","sequence":"additional","affiliation":[{"name":"Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK"},{"name":"Ethox Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Hodges","sequence":"additional","affiliation":[{"name":"Tommy\u2019s Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen\u2019s Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn F","family":"Carruthers","sequence":"additional","affiliation":[{"name":"Tommy\u2019s Centre for Maternal and Fetal Health Research, Medical Research Council Centre for Reproductive Health, Queen\u2019s Medical Research Institute, University of Edinburgh, Edinburgh, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2017,9,18]]},"reference":[{"key":"2025102708381874000_7.9.e017134.1","unstructured":"NICE. NICE clinical guideline 55: intrapartum care: care of healthy women and their babies during childbirth. 2012."},{"key":"2025102708381874000_7.9.e017134.2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(93)90047-G"},{"key":"2025102708381874000_7.9.e017134.3","first-page":"863","article-title":"Prolonged third stage of labor: morbidity and risk factors","volume":"77","author":"Combs","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2025102708381874000_7.9.e017134.4","doi-asserted-by":"publisher","DOI":"10.3109\/01443615.2010.531301"},{"key":"2025102708381874000_7.9.e017134.5","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/0029-7844(95)00327-N","article-title":"The association between manual removal of the placenta and postpartum endometritis following vaginal delivery","volume":"86","author":"Ely","year":"1995","journal-title":"Obstet Gynecol"},{"key":"2025102708381874000_7.9.e017134.6","first-page":"69","article-title":"Factors associated with postpartum hemorrhage with vaginal birth","volume":"77","author":"Combs","year":"1991","journal-title":"Obstet Gynecol"},{"key":"2025102708381874000_7.9.e017134.7","article-title":"Nitroglycerin for management of retained placenta","volume":"12","author":"Abdel-Aleem","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025102708381874000_7.9.e017134.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.1107.377"},{"key":"2025102708381874000_7.9.e017134.9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00222.2004"},{"key":"2025102708381874000_7.9.e017134.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2008.07.005"},{"key":"2025102708381874000_7.9.e017134.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2005.08.020"},{"key":"2025102708381874000_7.9.e017134.12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0959-289X(95)82102-G","article-title":"A new preparation of nitroglycerin for uterine relaxation","volume":"4","author":"Redick","year":"1995","journal-title":"Int J Obstet Anesth"},{"key":"2025102708381874000_7.9.e017134.13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000174612","article-title":"Sublingual nitroglycerin administered by spray versus tablet: comparative timing of hemodynamic effects","volume":"77","author":"Laslett","year":"1990","journal-title":"Cardiology"},{"key":"2025102708381874000_7.9.e017134.14","doi-asserted-by":"crossref","first-page":"J43","DOI":"10.1016\/0002-9149(90)91311-S","article-title":"Comparative evaluation of a new formulation of isosorbide dinitrate oral spray and sublingual nitroglycerin tablets","volume":"65","author":"Marmor","year":"1990","journal-title":"Am J Cardiol"},{"key":"2025102708381874000_7.9.e017134.15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/bdd.2510140203","article-title":"Plasma concentrations and hemodynamic effects of intravenous, sublingual, and aerosolized nitroglycerin in patients undergoing cardiac catheterization","volume":"14","author":"Curry","year":"1993","journal-title":"Biopharm Drug Dispos"},{"key":"2025102708381874000_7.9.e017134.16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF00266360","article-title":"A large scale comparative study in general practice with nitroglycerin spray and tablet formulations in elderly patients with angina pectoris","volume":"42","author":"Wight","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"2025102708381874000_7.9.e017134.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-016-1394-1","article-title":"The role of therapeutic optimism in recruitment to a clinical trial in a peripartum setting: balancing hope and uncertainty","volume":"17","author":"Hallowell","year":"2016","journal-title":"Trials"},{"key":"2025102708381874000_7.9.e017134.18","doi-asserted-by":"crossref","DOI":"10.1186\/s13063-016-1323-3","article-title":"Recruiting and consenting into a peripartum trial in an emergency setting: a qualitative study of the experiences and views of women and healthcare professionals","volume":"17","author":"Lawton","year":"2016","journal-title":"Trials"},{"key":"2025102708381874000_7.9.e017134.19","unstructured":"RCOG. Obtaining valid consent to participate in research while in Labour, in clinical governance\u00a0Advice No.6a2010. London: RCOG, 2015."},{"key":"2025102708381874000_7.9.e017134.20","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-7-13","article-title":"Issues of informed consent for intrapartum trials: a suggested consent pathway from the experience of the Release trial [ISRCTN13204258]","volume":"7","author":"Vernon","year":"2006","journal-title":"Trials"},{"key":"2025102708381874000_7.9.e017134.21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61752-9"},{"key":"2025102708381874000_7.9.e017134.22","doi-asserted-by":"crossref","first-page":"864.e1","DOI":"10.1016\/j.ajog.2015.07.039","article-title":"Risk factors for retained placenta","volume":"213","author":"Coviello","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"2025102708381874000_7.9.e017134.23","unstructured":"RCOG. Obtaining valid consent to participate in perinatal research where consent is time critical, in clinical governance Advice No.6a2010. London: RCOG, 2016."},{"key":"2025102708381874000_7.9.e017134.24","unstructured":"East 6. Statistical software for the design, simulation and monitoring clinical trials. Cambridge, MA: Cytel Inc. 2016."},{"key":"2025102708381874000_7.9.e017134.25","unstructured":"StataCorp. Stata statistical software: release 14. College Station, TX: StataCorp LP, 2015."},{"key":"2025102708381874000_7.9.e017134.26","unstructured":"British National Formulary. Medicines Complete. 2017 https:\/\/www.evidence.nhs.uk\/formulary\/bnf\/current."},{"key":"2025102708381874000_7.9.e017134.27","unstructured":"Curtis L . Unit costs of health and social care 2016. Canterbury: Personal Social Services Research Unit, 2016."},{"key":"2025102708381874000_7.9.e017134.28","unstructured":"Department of Health. NHS reference costs 2015-2016. London, UK: NHS, 2015."},{"key":"2025102708381874000_7.9.e017134.29","unstructured":"NICE. Approaches to bespoke economic evaluation In: Developing NICE guidelines: the manual. UK: National Institute For Health and Clinical Excellence, 2014."}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-017134","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:09:19Z","timestamp":1761581359000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-017134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,18]]},"published-print":{"date-parts":[[2017,9]]}},"alternative-id":["10.1136\/bmjopen-2017-017134"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-017134","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}